Shah Rajeev M. 4
4 · Satsuma Pharmaceuticals, Inc. · Filed Jun 16, 2020
Insider Transaction Report
Form 4
Shah Rajeev M.
Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2020-06-12+10,000→ 10,000 totalExercise: $26.99Exp: 2030-06-11→ Common Stock (10,000 underlying)
Holdings
- 4,681,858(indirect: See footnote)
Common Stock, $0.0001 par value
Footnotes (4)
- [F1]Includes (a) 3,923,460 shares of Common Stock that are held by RA Capital Fund and (b) 758,398 shares of Common Stock that are held in the Account.
- [F2]RA Capital Management, LLC (the "Advisor") is the general partner of RA Capital Healthcare Fund, L.P.("RA Capital Fund") and the investment advisor of an account owned by a separately managed account (the "Account"). Peter Kolchinsky is the sole manager of the Advisor, and Mr. Shah is a member of the Advisor. Mr. Shah has no pecuniary interest in the reported securities held by the Account and therefore disclaims beneficial ownership of those securities. Mr. Shah disclaims beneficial ownership of the reported securities held by RA Capital Fund except to the extent of his pecuniary interest therein.
- [F3]The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program.
- [F4]The option shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the first Annual Meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to the Non-Employee Director continuing in service on the Board through the applicable vesting date.